Results 141 to 150 of about 11,886 (196)

Emergency use of eculizumab in impending and manifest myasthenic crisis: a retrospective case series. [PDF]

Ther Adv Neurol Disord
Huang Y, Xiong Y, Zhan H, Wu F, Jiang Y, Zhang Y, Chen J, Zeng S, Zhang T, Xiong X, Chen Z, Yang F, Li G, Xu Q.   +13 more
europepmc   +1 more source

Time-Related Burden of Treatment With Parenterally Administered Complement Inhibitors: A Mixed Methods Observational Study Exploring Experiences among Patients With Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Health Sci Rep
Dingli D, Broderick L, Rizio AA, Rucker S, LaGasse K, Carty MK, Burton E, Gordon S, Yen GP, Paulose J, Geevarghese A, Lee S.   +11 more
europepmc   +1 more source

Epidemiology and care management of Paroxysmal Nocturnal Hemoglobinuria (PNH) in a real-world setting in France: Description from the French National Hospitalization Database. [PDF]

PLoS One
Peffault de Latour R, Pibre S, Vercruyssen J, Desjuzeur-Bellais ML, Pau D, Bénard S, Chillotti L, Grandfils N.   +7 more
europepmc   +1 more source

Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany. [PDF]

Eur J Neurol
Gerischer L, Stein M, Schneider A, Tangen H, Loris J, Glaubitz S, Zschüntzsch J, Oy UH, Schubert C, Heesen C, Schlag M, Hagenacker T, Oeztuerk M, Ruck T, Doksani P, Dusemund C, Herdick M, Herzig-Nichtweiß J, Mergenthaler P, Stascheit F, Suboh A, Schwarz L, Hoffmann S, Meisel A, Lehnerer S.   +24 more
europepmc   +1 more source

Subsequent treatment strategies following rituximab-resistance in AQP4-IgG+ neuromyelitis optica spectrum disorder: a case series. [PDF]

Front Immunol
Deng M, Chen L, Chen W, Zeng K, Yao Y, Chen H, Lin A.   +6 more
europepmc   +1 more source

Rapid Recognition of Carfilzomib-Induced Thrombotic Microangiopathy and Early Application of Eculizumab Successfully Rescued Two Relapsed Myeloma Patients. [PDF]

Chronic Dis Transl Med
Wang Z, Zheng H, Wang W, Shi X, Wei Y, Li C, Zhuang J.   +6 more
europepmc   +1 more source

Extreme Hyperhemolysis Syndrome in a Patient With Sickle Cell Disease Successfully Managed With Eculizumab: A Case of Survival at 1.2 g/dL Hemoglobin. [PDF]

Cureus
Cordeiro I, Cerca C, Pinheiro M, Pratas C, Germano N.   +4 more
europepmc   +1 more source

Successful living kidney transplantation in a T-cell flow cytometry crossmatch-positive patient with atypical hemolytic uremic syndrome treated with an anti-C5 antibody: a case report. [PDF]

CEN Case Rep
Okumi M, Okuno N, Kurose R, Segawa Y, Komaki K, Miyashita M, Ueda T, Ukimura O, Tamagaki K.   +8 more
europepmc   +1 more source

Efficacy of Ravulizumab During the Acute Phase of Neuromyelitis Optica Spectrum Disorder. [PDF]

Case Rep Neurol Med
Tsuzaki K, Mitsui G, Inagaki Y, Uehara N, Wada S, Hamano T.   +5 more
europepmc   +1 more source

Efficacy and Safety of Crovalimab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Meta-Analysis. [PDF]

EJHaem
Javaid H, Qadri M, Ali H, Chilaka CF, Syed W, Habib E, Zahin F, Musani A, Khan SA, Rizwan D, Saddique MN, Hajj F.   +11 more
europepmc   +1 more source